Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
International guidelines recommend surgical revascularisation for unprotected left main (ULM) coronary artery disease. The introduction of drug-eluting stents (DES) as an emergency therapy has resulted in increasing numbers of patients having stents placed in ULM. As a consequence, important data on...
Main Authors: | De Caterina, A, Cuculi, F, Banning, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
by: Stone, GW, et al.
Published: (2016) -
Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005) -
Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
by: Schrale, R, et al.
Published: (2007) -
Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
by: Blackman, D, et al.
Published: (2004) -
Stents versus bypass grafting for left main coronary artery disease.
by: Arnold, JR, et al.
Published: (2008)